SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-24-009173
Filing Date
2024-05-01
Accepted
2024-05-01 16:25:50
Documents
2
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1587
2 POWER OF ATTORNEY exhibit24-1.txt EX-24.1 3134
  Complete submission text file 0001062993-24-009173.txt   6147
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 28 SEVINOR RD MARBLEHEAD MA 01945
Business Address
Kowalsky Matthew Paul (Reporting) CIK: 0001705824 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35839 | Film No.: 24903421